| Pruitthealth - Athens Heritage | |
| 960 Hawthorne Avenue, Athens, Georgia 30606 | |
| (706) 549-1613 | |
| Name | Pruitthealth - Athens Heritage |
|---|---|
| Location | 960 Hawthorne Avenue, Athens, Georgia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 104 |
| Occupancy Rate | 77.21% |
| Medicare ID (CCN) | 115509 |
| Legal Business Name | Pruitthealth - Athens Heritage Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1316993769 |
| Organization Name | PRUITTHEALTH - ATHENS HERITAGE LLC |
| Doing Business As | PRUITTHEALTH - ATHENS HERITAGE |
| Address | 960 Hawthorne Ave, Athens, GA 30606 |
| Phone Number | 706-549-1613 |
News Archive
More than 70 years after the first sulfa drugs helped to revolutionize medical care and save millions of lives, St. Jude Children's Research Hospital scientists have determined at an atomic level the mechanism these medications use to kill bacteria. The discovery provides the basis for a new generation of antibiotics that would likely be harder for bacteria to resist and cause fewer side effects.
Tissue injury, such as occurs in response to a lack of oxygen, promotes an influx of immune cells to the site of damage.
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
More than 70 years after the first sulfa drugs helped to revolutionize medical care and save millions of lives, St. Jude Children's Research Hospital scientists have determined at an atomic level the mechanism these medications use to kill bacteria. The discovery provides the basis for a new generation of antibiotics that would likely be harder for bacteria to resist and cause fewer side effects.
Tissue injury, such as occurs in response to a lack of oxygen, promotes an influx of immune cells to the site of damage.
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.66 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.49 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.7 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 8.33 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.69 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.18 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.36 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.98 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.47 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.72 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.89 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.18 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.37 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 87.42 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.43 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.29 | 82.93 |
News Archive
More than 70 years after the first sulfa drugs helped to revolutionize medical care and save millions of lives, St. Jude Children's Research Hospital scientists have determined at an atomic level the mechanism these medications use to kill bacteria. The discovery provides the basis for a new generation of antibiotics that would likely be harder for bacteria to resist and cause fewer side effects.
Tissue injury, such as occurs in response to a lack of oxygen, promotes an influx of immune cells to the site of damage.
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
The University of Arkansas will host the 2010 Advances in Breast Cancer Research workshop sponsored by the National Science Foundation on Oct. 26-29. The workshop will bring together researchers in nanotechnology, biomagnetics, microwave imaging, acoustics, laser and biochemistry fields with researchers from radiology, oncology and breast surgery.
› Verified 3 days ago
Oaks - Athens Skilled Nursing, The Location: 490 Kathwood Dr, Athens, Georgia 30607 Phone: (706) 355-7400 | |
University Nursing & Rehab Ctr Location: 180 Epps Bridge Rd, Athens, Georgia 30606 Phone: (706) 549-5382 | |
Pruitthealth - Athens Heritage Location: 960 Hawthorne Avenue, Athens, Georgia 30606 Phone: (706) 549-1613 | |